EUVIMEDEUVIMED entdecken
Crossref

Partial D variant with demonstrated risk of D alloimmunization in the Australian Indigenous population

Emma Palfreyman iD, Jenny Morrison, Brett Wilson, Glenda Millard, Yew Wah Liew, Tanya Powley, James Daly

Vox Sanguinis · 2025

DOI: 10.1111/vox.70113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2025. Verfasst von Emma Palfreyman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pathology and Clinical Governance, Australian Red Cross Lifeblood, Brisbane, Australia. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Rh Isoimmunization, Polymorphism, Single Nucleotide. Die Arbeit nennt 9 Literaturangaben. Gefördert von: Australian Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Two prior publications have identified a novel RHD variant in the Australian population with the pattern of single nucleotide variation (SNV) c.186G>T, c.410C>T, c.455A>C, c.602C>G, c.604G>A, c.733G>C, and a deletion or rearrangement with RHCE exon 9. The Australian Red Cross Lifeblood provides testing across Australia, and over a period of 8 years, this same RHD variant has been noted, with some cases presenting with allogeneic anti‐D. Materials and Methods Cases with the combination of SNVs were identified with the RHD BeadChip™ panel and massively parallel sequencing, and were collated. Clinical presentation, phenotype and the specificity of any antibodies were also reviewed.

Results

Twelve cases of the same pattern of SNV and exon change were identified. There was consistent finding of c.186G>T, c.410C>T, c.455A>C, c.602C>G, c.604G>A and c.733G>C, in association with RHCE replacement of exon 9. All cases except one were phenotypically D‐positive. Nine of 12 cases presented with anti‐D antibodies, often associated with pregnancy. Where ethnicity was reported, all individuals were of Australian Indigenous ethnicity.

Conclusion

This RHD variant is observed to date only in people of Australian Indigenous ethnicity and has clinical relevance. With wider knowledge of the variant, it is anticipated that there will be increased screening in this population, especially in women of childbearing age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rh-Hr Blood-Group SystemRh IsoimmunizationPolymorphism, Single NucleotideHumansAustraliaFemaleMaleAdultExonsIsoantibodies

Stichwörter der Autor:innen

DIIIRHD geneticsalloimmunization Dc.604G>A

Substanzen

Rh-Hr Blood-Group SystemRho(D) antigenIsoantibodies

Autor:innen und Institutionen

  • Pathology and Clinical Governance, Australian Red Cross Lifeblood, Brisbane, Australia.
  • Red Cell Reference, Australian Red Cross Lifeblood, Brisbane, Australia.

ORCID-Profile: Emma Palfreyman

Förderung

  • Australian Government

Zitieren

APA

Palfreyman, E., Morrison, J., Wilson, B., Millard, G., Liew, Y. W., Powley, T., & Daly, J. (2025). Partial D variant with demonstrated risk of D alloimmunization in the Australian Indigenous population. Vox Sanguinis. https://doi.org/10.1111/vox.70113

Vancouver

Palfreyman E, Morrison J, Wilson B, Millard G, Liew YW, Powley T, et al. Partial D variant with demonstrated risk of D alloimmunization in the Australian Indigenous population. Vox Sanguinis. 2025. doi:10.1111/vox.70113

BibTeX
@article{Palfreyman2025,
  author = {Palfreyman, Emma and Morrison, Jenny and Wilson, Brett and Millard, Glenda and Liew, Yew Wah and Powley, Tanya and Daly, James},
  title = {Partial D variant with demonstrated risk of D alloimmunization in the Australian Indigenous population},
  journal = {Vox Sanguinis},
  year = {2025},
  doi = {10.1111/vox.70113}
}
Kostenlos starten →